Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis. - Wikidata - awgldk - TriplyDB

Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis.

Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis.

http://www.wikidata.org/entity/Q41160044

about

Permissive role of nitric oxide in endothelin-induced migration of endothelial cells Secretion of endothelin-1 and endothelin-3 by human cultured vascular smooth muscle cells Methods for analysis of matrix metalloproteinase regulation of neutrophil-endothelial cell adhesion Vascular endothelial dysfunction and pharmacological treatment The Role of the Endothelin System in the Vascular Dysregulation Involved in Retinitis Pigmentosa Physiological antagonism of endothelin-1 in human conductance and resistance coronary artery Evidence for a role of endothelin 1 and protein kinase C in nitroglycerin tolerance Endothelin ETA receptor blockade restores NO-mediated endothelial function and inhibits atherosclerosis in apolipoprotein E-deficient mice Protective effects of tanshinone ⅡA on endothelial progenitor cells injured by tumor necrosis factor-α.Thermotherapy reduces blood pressure and circulating endothelin-1 concentration and enhances leg blood flow in patients with symptomatic peripheral artery disease Retinal vein occlusions: The potential impact of a dysregulation of the retinal veins High frequency rotational ablation: an alternative in treating coronary artery stenoses and occlusions Raised plasma endothelin in unstable angina and non-Q wave myocardial infarction: relation to cardiovascular outcome ET-1 plasma levels and ocular blood flow in retinitis pigmentosa.Sex differences in endothelin-1-mediated vasoconstrictor tone in middle-aged and older adults.Telomere length and replicative aging in human vascular tissues.A pivotal role of nitric oxide in endothelial cell dysfunction.Tendency to angry rumination predicts stress-provoked endothelin-1 increase in patients with coronary artery disease Endothelin-1 impairs nitric oxide signaling in endothelial cells through a protein kinase Cdelta-dependent activation of STAT3 and decreased endothelial nitric oxide synthase expression.Testing for endothelial dysfunction.Endothelial function as a functional expression of cardiovascular risk factors.Evidence for the endothelin system as an emerging therapeutic target for the treatment of chronic pain Long-term administration of endothelin receptor antagonist improves coronary endothelial function in patients with early atherosclerosis.Alterations in nitric oxide and endothelin-1 bioactivity underlie cerebrovascular dysfunction in ApoE-deficient mice Obesity-related inflammation & cardiovascular disease: efficacy of a yoga-based lifestyle intervention Role of endothelin in human hypertension.Plasma C-terminal pro-endothelin-1 is associated with target-organ damage in African Americans with hypertension.Endothelial dysfunction in the pathogenesis of atherosclerosis.Endothelial function, endothelin-1, and fibrinogen in young women using the vaginal contraceptive ring.Depression predicts elevated endothelin-1 in patients with coronary artery disease.Endothelin-1 and endothelin receptor antagonists as potential cardiovascular therapeutic agents.Endothelin receptor antagonists in cardiology clinical trials.Heart ischaemia-reperfusion induces local up-regulation of vasoconstrictor endothelin ETB receptors in rat coronary arteries downstream of occlusion The therapeutic potential of endothelin-1 receptor antagonists and endothelin-converting enzyme inhibitors on the cardiovascular system.Autonomic contribution to endothelin-1 increase during laboratory anger-recall stress in patients with coronary artery disease Endothelin receptor expression and pharmacology in human saphenous vein graft.Endothelin-1 enhances neutrophil adhesion to human coronary artery endothelial cells: role of ET(A) receptors and platelet-activating factor.Orphan nuclear receptor Nur77 is a novel negative regulator of endothelin-1 expression in vascular endothelial cells.CRF2 receptors are highly expressed in the human cardiovascular system and their cognate ligands urocortins 2 and 3 are potent vasodilators.Plasma endothelin-1 concentrations in patients with retinal vein occlusions.

P2860

Q24313558-B122E072-0C1E-4FE4-942A-C8E5FA9405F3 Q24552364-AA38837E-EF4F-42FF-A94D-FE0C6251D085 Q24797480-6FA671D2-D929-48FB-8FFD-A40F05B9703F Q26774561-8952BA43-0315-4230-A301-FB2B5D7E2A57 Q26776382-8494D3EF-84C0-46F7-821D-B9F48510ABCA Q28366585-6DE75443-35E5-4BBF-8062-9B90CEE6B1A5 Q28367691-C6DE1F3D-BA2B-4249-80B1-754FBDA59926 Q28584822-AF9B055E-FD97-4EF2-888B-04D8E0C255E3 Q29347118-808AEF89-94B9-4CE5-A6F4-1009D6B45E98 Q31110191-F1EBAB4A-D37F-49C9-840A-DB4513F8AD90 Q33393778-D5B1A93F-50A3-418F-A7C3-87718EB30CE0 Q33613429-7FFF9DBE-D7EF-4771-A8D7-A14EBBA6B52D Q33614332-30341DF7-F921-4479-A54D-7DE79DB14341 Q33632123-C778D5AB-F694-4816-B343-621BD9A60A93 Q33686561-10B7048C-4A37-467A-A778-B013E3F401B0 Q33763501-9BEFDA4B-651A-4E4A-97A3-DEA131B5D189 Q33848393-F87687BE-4F9D-43F7-A27C-6CC823E6B874 Q33857649-1E19D81D-9F54-4111-A021-DDCA263D99D4 Q33892724-FFCB8823-F5A8-4456-9F84-C9B700292F0C Q34008359-C05CC59E-7E74-456B-96CA-417836332B22 Q34027133-59F2206E-5AF3-4ABF-B465-A068319022B0 Q34140692-744DA3FD-FD6A-4193-B38E-190637D73138 Q34157915-CC6A6AF0-59C2-4F7D-B21C-E556B494F73E Q34171317-FB59FC4B-8CD1-4655-8516-9C05EC7C6853 Q34186113-1F5D33E1-CEC4-42C9-930D-78C22DDBB375 Q34210942-C4CC1686-00D1-4472-9756-AA97270BA1A9 Q34213510-27997908-1BE1-45D3-AB27-082DBA5D8E68 Q34430443-AAA055D5-720A-46AC-B866-BD7DF0D6D070 Q34447839-6E32AF77-25BA-4FDD-9BFF-BA39B8EE4B6D Q34468833-516673F0-516E-41CF-8B20-8B0BA47234AA Q34496108-7491FCA7-A6BB-40CE-AD68-9507B9CD0B03 Q34544685-6F0BD369-0CAB-42D8-B0CC-D95546855D10 Q34570744-50423B5E-2CF6-452B-A3B1-852FF714DA87 Q35001002-4ECC3961-AC4A-4E3F-A77B-9068D135D406 Q35017010-B9499ACC-908D-4926-AF27-7DB9D1B98159 Q35028439-4025EB75-C873-418D-BDA8-9BF3657A8814 Q35028995-8FCEAD42-5F18-47CA-B643-FF7D82DA66DA Q35032724-9C3AD42F-A113-46B3-BFA0-E80DDB3AF1F7 Q35047772-BD24B399-3787-45CB-BBF3-2B671D133312 Q35304943-B590D53C-D76D-45FE-8799-A72555D73C05

P2860

Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis.

http://www.wikidata.org/entity/Q41160044

description

1991 nî lūn-bûn

@nan

1991年の論文

@ja

1991年論文

@yue

1991年論文

@zh-hant

1991年論文

@zh-hk

1991年論文

@zh-mo

1991年論文

@zh-tw

1991年论文

@wuu

1991年论文

@zh

1991年论文

@zh-cn

name

Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis.

@en

type

label

Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis.

@en

prefLabel

Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis.

@en

P1433

Q41160044-F5F79060-75E2-4308-B119-C118EAF3288A

P1476

Q41160044-74272947-2240-413E-B8FC-95AFBBB1A6E7

P2093

Q41160044-0404C8F0-2AAC-4A2E-8CB0-FFBBCA162E38

Q41160044-0C92E11D-3A8D-4318-A9A3-137CCEBB753D

Q41160044-1A1DE791-3125-474A-9564-D646AAF2A86F

Q41160044-3AFF0C9C-2871-4AC8-AD0D-40BBE49F2B7E

Q41160044-4B4765A6-E9A3-4883-8978-83EBEE9ED4FB

Q41160044-DCE967E2-305E-49E7-BA6E-9A5234211D5E

P304

Q41160044-74A4B652-0B0F-436D-8E51-FCFF8782F92C

P31

Q41160044-4F69F3DC-2371-458B-859C-26380C6648D7

P356

Q41160044-09F0CB0A-4DD5-4099-ABD5-520BE3C34ECD

P407

Q41160044-481D39AB-DA4C-4309-A577-E129FEC7541A

P433

Q41160044-4E7D2CA3-3104-4A83-B495-3F126C674BAD

P478

Q41160044-1146E7F3-31AE-4DF0-BCBF-BC57F959E608

P577

Q41160044-6FCF4C84-EFF7-4305-8D67-E2B7578431F5

P698

Q41160044-6509E555-55E1-46A3-BE31-22A4717E2A0A

P921

Q41160044-7B9A6411-459F-43FA-9039-DC6107809ACE

P356

NEJM199110033251404

P1433

The New England Journal of Medicine

P1476

Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis.

@en

P2093

Burnett JC Jr

http://www.w3.org/2001/XMLSchema#string

Edwards BS

http://www.w3.org/2001/XMLSchema#string

Hallett JW

http://www.w3.org/2001/XMLSchema#string

Heublein DM

http://www.w3.org/2001/XMLSchema#string

Lerman A

http://www.w3.org/2001/XMLSchema#string

Sandberg SM

http://www.w3.org/2001/XMLSchema#string

P304

997-1001

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1056/NEJM199110033251404

http://www.w3.org/2001/XMLSchema#string

P407

P433

14

http://www.w3.org/2001/XMLSchema#string

P478

325

http://www.w3.org/2001/XMLSchema#string

P577

1991-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

1886637

http://www.w3.org/2001/XMLSchema#string

P921

atherosclerosis